Earnings ·
Humana Inc. reaffirmed its full-year 2026 earnings guidance during investor meetings scheduled between September 1 and…
HUMHumana Inc
Humana Inc. reaffirmed its full-year 2026 earnings guidance during investor meetings scheduled between September 1 and September 30, 2026. The company projects diluted GAAP EPS of at least $6.52 and Adjusted (non-GAAP) EPS of at least $9.00 for the year ending December 31, 2026. This guidance remains consistent with previous announcements from July 29, 2026. Management noted that while Adjusted EPS is stable, GAAP EPS may fluctuate due to ongoing value creation initiatives and strategic actions. The company also stated it will not comment on 2027 Medicare Advantage Star Ratings until CMS releases final data in October. Humana Inc. operates in the managed healthcare industry, providing health insurance products primarily through Medicare Advantage plans.